Join us at [time] on [date] for a discussion of comprehensive genomic profiling, exploring the common barriers to use, and discovering how Foundation Medicine can help you overcome these barriers to help inform decision-making and personalize patient care.
Fadi Braiteh, MD
Dr. Braiteh is a medical oncologist and Director of the Translational Oncology Program (TOP)-Phase I and GI Malignancies Program for Comprehensive Cancer Centers of Nevada. He is board-certified in medical oncology and palliative medicine and specializes in the area of gastrointestinal and thoracic oncology as well as the development of novel anti-cancer agents through research.
Prior to joining CCCN in 2010, Dr. Braiteh worked as a medical oncologist and Director of the Phase I Program and Drug Development Center at the Cancer and Hematology Centers of Western Michigan in Grand Rapids, Michigan. During this time, he was a Clinical Assistant Professor of Medicine at the School of Human Medicine at Michigan State University, and a scientific investigator for Program of Translational Medicine and Phase I clinical trials at Van Andel Research Institute in Grand Rapids, Michigan.
Dr. Fadi Braiteh earned his medical degree in 1998 from Saint Joseph University in Beirut, Lebanon. In 2003, he completed his internal medicine internship and residency at the Hospital of Saint Raphael, Yale School of Medicine in New Haven, Connecticut. From 2003-2009, Dr. Braiteh completed three fellowships – medical oncology, phase I drug development and palliative care and symptom management – at the University of Texas M.D. Anderson Cancer Center in Houston, Texas, while he earned PhD credits for a program in molecular biology and human investigation.